Undervalued Dividend Growth Stock of the Week: Pfizer (PFE)
This is a high-quality company with durable competitive advantages. With an exciting upcoming spin-off, a yield more than twice as high as the S&P 500, a modest payout ratio, strong dividend growth, and the potential that shares are 6% undervalued, this looks like a relatively attractive stock in an otherwise elevated market.
Read More